APA aipamena

Essuman, K., Summers, D. W., Sasaki, Y., Mao, X., DiAntonio, A., & Milbrandt, J. (2017). The SARM1 Toll/Interleukin-1 Receptor (TIR) Domain Possesses Intrinsic NAD(+) Cleavage Activity that Promotes Pathological Axonal Degeneration. Neuron.

Chicago Style aipamena

Essuman, Kow, Daniel W. Summers, Yo Sasaki, Xianrong Mao, Aaron DiAntonio, and Jeffrey Milbrandt. "The SARM1 Toll/Interleukin-1 Receptor (TIR) Domain Possesses Intrinsic NAD(+) Cleavage Activity That Promotes Pathological Axonal Degeneration." Neuron 2017.

MLA aipamena

Essuman, Kow, et al. "The SARM1 Toll/Interleukin-1 Receptor (TIR) Domain Possesses Intrinsic NAD(+) Cleavage Activity That Promotes Pathological Axonal Degeneration." Neuron 2017.